Stada Group
STADA Arzneimittel AG is headquartered in Bad Vilbel, Germany. The company focuses on a three-pillar strategy consisting of generics, speciality pharma and non-prescription consumer healthcare products. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. In the financial year 2020, STADA achieved group sales of EUR 3,010.3 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 713.3 million. As of 31 December 2020, STADA employed 12,301 people worldwide.
Best Sellers
More About Stada Group
Helping people, help themselves
STADA is significantly expanding its European Consumer Healthcare portfolio by agreeing to acquire a portfolio of well-established local and regional consumer healthcare brands from Sanofi in countries predominantly in Europe. Sanofi is a global biopharmaceutical company focused on human health. They prevent illness with vaccines and provide innovative treatments to fight pain and ease suffering. Sanofi stands by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
